Form 4: Incyte EVP Sells Stock for Tax Obligations
Insider Transaction Report
Incyte's EVP & Chief Scientific Officer, Patrick A. Mayes, disposed of 1,569 shares of common stock at $86.7 per share to cover tax withholding obligations related to restricted stock units.
Summary
- Patrick A. Mayes, Executive Vice President & Chief Scientific Officer of Incyte Corp (INCY), reported a transaction on October 1, 2025.
- The transaction involved the disposition of 1,569 shares of Incyte common stock.
- The shares were disposed of at a price of $86.7 per share.
- This disposition was categorized as a 'F' transaction code, indicating shares withheld by the Issuer to satisfy tax withholding obligations due at the settlement of previously reported restricted stock units.
- Following this transaction, Patrick A. Mayes beneficially owns 65,819 shares of Incyte common stock directly.
- Of the beneficially owned shares, 59,858 shares are issuable pursuant to previously reported restricted stock units that have not yet vested.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is neutral in sentiment as it is a standard part of executive compensation and not indicative of positive or negative company performance or outlook.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries, including the biotechnology and pharmaceutical sector where Incyte operates. It does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and represents a small fraction of the company's outstanding shares.
- Employees: No direct impact on the broader employee base, but it reflects standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of transaction (disposition of common stock for tax withholding). |
| 10/03/2025 | Date the Form 4 was signed by Elizabeth Feeney, Attorney-In-Fact for Patrick A. Mayes. |
Keywords
Incyte, INCY, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.